Qiong Shi Selected Research

Pulmonary Hypertension

1/2020	Characterization of two kcnk3 genes in Nile tilapia (Oreochromis niloticus): Molecular cloning, tissue distribution, and transcriptional changes in various salinity of seawater.
1/2019	Molecular cloning of two kcnk3 genes from the Northern snakehead (Channa argus) for quantification of their transcriptions in response to fasting and refeeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiong Shi Research Topics

Disease

73	Neoplasms (Cancer) 01/2024 - 09/2004
29	Melanoma (Melanoma, Malignant) 01/2024 - 01/2016
26	Glioma (Gliomas) 11/2017 - 05/2012
9	Inflammation (Inflammations) 01/2023 - 03/2009
8	Vitiligo 01/2020 - 02/2013
8	Carcinogenesis 09/2017 - 01/2010
8	Osteosarcoma (Osteogenic Sarcoma) 10/2015 - 01/2010
8	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 09/2004
7	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2006
4	Infections 01/2023 - 05/2016
4	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 03/2013
3	Polyploidy 03/2022 - 01/2020
3	Non-alcoholic Fatty Liver Disease 07/2021 - 12/2019
3	Body Weight (Weight, Body) 12/2019 - 10/2009
3	Breast Neoplasms (Breast Cancer) 05/2016 - 08/2013
3	Spontaneous Abortion (Miscarriage) 01/2012 - 05/2008
3	Colonic Neoplasms (Colon Cancer) 08/2011 - 11/2008
3	Adenoma (Adenomas) 11/2008 - 09/2004
2	Virus Diseases (Viral Diseases) 01/2023 - 08/2021
2	Adenocarcinoma of Lung 11/2022 - 11/2017
2	Aortic Valve Disease 06/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2019
2	Triple Negative Breast Neoplasms 07/2021 - 04/2020
2	Pulmonary Hypertension 01/2020 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 05/2013
2	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2015 - 11/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2014 - 09/2013
2	Carcinoma (Carcinomatosis) 08/2013 - 09/2004

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2007
10	Phosphotransferases (Kinase)IBA 01/2024 - 10/2012
9	CateninsIBA 11/2022 - 01/2011
9	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2012
8	CytokinesIBA 01/2024 - 09/2015
8	Messenger RNA (mRNA)IBA 01/2023 - 05/2008
7	EnzymesIBA 10/2023 - 07/2017
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2014
5	Therapeutic UsesIBA 01/2024 - 03/2020
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2009
5	ProstaglandinsIBA 08/2011 - 09/2004
4	RNA (Ribonucleic Acid)IBA 10/2023 - 08/2009
4	Aurora Kinase BIBA 08/2023 - 01/2020
4	Immune Checkpoint InhibitorsIBA 08/2023 - 01/2018
4	Interleukin-8 (Interleukin 8)IBA 07/2021 - 05/2016
4	LigandsIBA 12/2020 - 01/2006
4	PhosphoproteinsIBA 11/2017 - 04/2013
4	ErbB Receptors (EGF Receptor)IBA 11/2017 - 01/2006
4	Protein Kinases (Protein Kinase)IBA 10/2015 - 11/2009
4	Small Interfering RNA (siRNA)IBA 01/2015 - 08/2013
4	Prostaglandins EIBA 08/2011 - 09/2004
3	Peptides (Polypeptides)IBA 12/2023 - 11/2009
3	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 10/2023 - 01/2020
3	VemurafenibIBA 02/2023 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023 - 05/2013
3	CalciumIBA 06/2022 - 01/2020
3	Alkaline PhosphataseIBA 01/2022 - 01/2020
3	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 10/2012
3	quinone (benzoquinone)IBA 05/2019 - 11/2015
3	Growth Differentiation Factor 2IBA 02/2014 - 11/2010
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010 - 01/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2024 - 10/2016
2	ChemokinesIBA 01/2024 - 07/2017
2	Inositol (Myoinositol)IBA 01/2024 - 07/2017
2	Branched-Chain Amino AcidsIBA 10/2023 - 10/2023
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 10/2023 - 10/2023
2	Antimitotic AgentsIBA 08/2023 - 07/2022
2	ProgranulinsIBA 11/2022 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 07/2021 - 12/2019
2	Serine (L-Serine)FDA Link 01/2021 - 01/2015
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	SuspensionsIBA 01/2020 - 05/2012
2	Oleic Acid (Oleate)IBA 01/2020 - 12/2019
2	potassium channel subfamily K member 3IBA 01/2020 - 01/2019
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2019 - 11/2017
2	HMGB1 Protein (HMG1)IBA 05/2019 - 10/2016
2	Polychlorinated Biphenyls (PCBs)IBA 05/2019 - 11/2015
2	Cytochromes c (Cytochrome c)IBA 01/2019 - 07/2015
2	Ubiquitin-Specific ProteasesIBA 01/2018 - 04/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2016
2	Metalloproteases (Metalloproteinases)IBA 01/2018 - 10/2012
2	Conotoxins (Conotoxin)IBA 12/2017 - 01/2017
2	Peptide Initiation Factors (Initiation Factor)IBA 11/2017 - 07/2017
2	LipidsIBA 10/2017 - 12/2010
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2017 - 06/2015
2	TransducinIBA 09/2017 - 06/2015
2	Monomeric GTP-Binding ProteinsIBA 01/2017 - 04/2013
2	MelatoninIBA 01/2017 - 03/2009
2	tetrachlorobenzoquinoneIBA 12/2016 - 07/2015
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 07/2016 - 08/2013
2	Complementary DNA (cDNA)IBA 05/2016 - 02/2015
2	2,3,5- trichloro- 6- phenyl- (1,4)benzoquinoneIBA 11/2015 - 07/2015
2	BromidesIBA 10/2015 - 03/2013
2	plumbaginIBA 07/2015 - 02/2015
2	Cadherins (E-Cadherin)IBA 01/2015 - 05/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2014 - 08/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2014 - 08/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013 - 02/2011

Therapy/Procedure

29	Therapeutics 12/2023 - 11/2009
8	Immunotherapy 01/2024 - 10/2018
7	Drug Therapy (Chemotherapy) 09/2019 - 02/2011